Sigrid Therapeutics today announced that the Stockholm Material Hub, a long-term collaboration partner of the…
Liu MingMarch 25, 2020
New study in mice published in Nanomedicine shows Sigrid’s medical device SiPore15 prevents weight gain…
Liu MingJanuary 15, 2020
Sigrid Therapeutics Reports Significant Blood Sugar Reduction with Excellent Safety Profile in STAR Trial with…
Liu MingSeptember 26, 2019
Stockholm, Sweden, September 5, 2019 – Sigrid Therapeutics AB, an innovative technology company developing a…
Liu MingSeptember 5, 2019
First-in-Class MSP (mesoporous silica particle) based therapy targets blood sugar and other metabolic risk factors.…
MorganJuly 16, 2019
First-in-Class MSP (mesoporous silica particle) based therapy targets blood sugar and other metabolic risk factors…
MorganJune 4, 2019
Sigrid Therapeutics Announces SiPore15TM Selected for Oral Presentation at Upcoming 28th European Diabetics Congress in Edinburgh Novel silica…
MorganMay 21, 2019
Sigrid Therapeutics Announces SiPore15TM Data Presentation at the American Diabetes Association 79th Scientific Sessions …
MorganApril 9, 2019
Today you can read about Sigrid and our research in Svenska Dagbladet, one of Sweden’s…
MorganMarch 7, 2019